Loading... Please wait...

Call 408-734-3800 / Toll Free 877-272-7241

Menu

Triptorelin Acetate

Triptorelin Acetate

 

Triptorelin Generic peptide for prostate cancer research

Triptorelin (pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2) is a decapeptide GnRH (LHRH) agonist used to treat men with prostate cancer, women who have uterine fibroids or endometriosis, and boys and girls when puberty occurs prematurely. This peptide acts as a gonadotopin-releasing hormone agonist by stimulating the pituitary gland resulting in a decrease in a release of follicle stimulating and luteinizing hormones. Triptorelin is sold under the trade names Trelstar by Watson Pharmaceuticals and Diphereline by Ferring Pharmaceuticals.

SEQUENCE:  pGlu-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2
MOLECULAR FORMULA:  C64H82N18O13
MOLECULAR WEIGHT:  1311.5
CAS REGISTRY NUMBER:  [57773-63-4]
SYNONYMS:  Decapeptyl, Diphereline, Gonapeptyl, and Trelstar
CLINICAL AREA:  Assisted Reproduction, Cancer

DMF SCHEDULE: 

CFDA: 3/2014